Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

Delayed Data
As of Jun 23
 -0.85 / -3.20%
Today’s Change
Today|||52-Week Range
Biotech Stocks Finally Stage Breakthrough
Jun 22 / TheStreet.com - Paid Partner Content
Omeros (OMER) Worth a Look: Stock Adds 11.8% in Session
Jun 13 / Zacks.com - Paid Partner Content
Omeros (OMER) Hits New 52-Week High on Positive FDA Decision
Jun 16 / Zacks.com - Paid Partner Content